Found: 5
Select item for more details and to access through your institution.
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
- Published in:
- Osteoporosis International, 2005, v. 16, n. 8, p. 943, doi. 10.1007/s00198-004-1800-5
- By:
- Publication type:
- Article
Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The relationship of 3′ vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
- Published in:
- Nephrology Dialysis Transplantation, 2004, v. 19, n. 9, p. 2259, doi. 10.1093/ndt/gfh273
- By:
- Publication type:
- Article
Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study.
- Published in:
- Nephrology Dialysis Transplantation, 2001, v. 16, n. 11, p. 2232, doi. 10.1093/ndt/16.11.2232
- By:
- Publication type:
- Article
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes.
- Published in:
- Clinical Endocrinology, 2003, v. 58, n. 3, p. 365, doi. 10.1046/j.1365-2265.2003.01724.x
- By:
- Publication type:
- Article